Ideological rigidity is not only keeping us from making inroads with mainstream society and growing our numbers—but effectively preventing us from accomplishing any actual policy goals.
pharma mergers
Follow:
-
Why Are Drug Monopolies Running Amok? Meet Deborah Feinstein
After going back and forth through the revolving door, Feinstein heads the Federal Trade Commission’s Bureau of Competition, which has effectively abandoned all attempts to block Big Pharma mergers.